NAUT
Nautilus Biotechnology, Inc.
Key Financials
Net Income
$-59001000
↑ 16.6%
Operating Income
$-576035
N/A
EPS (Diluted)
$-0.47
↑ 16.1%
Total Assets
$191.1M
↓ 21.3%
Cash & Equivalents
$12.4M
↓ 55.2%
Shareholders' Equity
$157.0M
↓ 24.8%
Total Liabilities
$34.1M
↑ 0.4%
Operating Cash Flow
$-50696000.00
↑ 14.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 6/30/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| SCHEDULE 13D/A | 6/4/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| ARS | 4/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NAUT |
| Company Name | Nautilus Biotechnology, Inc. |
| CIK | 1808805 |
| Sector | Laboratory Analytical Instruments |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 206-333-2001 |